Indian astronaut Shubhanshu Shukla is part of a landmark ISS mission studying how diabetes behaves in space, aiming to make future space travel possible for insulin-dependent patients and improve care ...

This is because it is very hard to control blood sugar levels in space, where there is no gravity. But now, the Ax-4 mission ...

Indian astronaut Shubhanshu Shukla is part of the Ax-4 mission studying diabetes in space. This research could transform ...

The diabetes conference featured a debate about over-the-counter glucose monitors and updates on upcoming devices, including ...

Every other year, the congress brings children ages 4 to 17 with Type 1 diabetes from all 50 states to the nation's capital ...

India approves Eli Lilly’s Mounjaro KwikPen, a once-weekly injection for type 2 diabetes and obesity, offering dual hormone ...

India’s drug regulator has approved Eli Lilly and Company’s diabetes and obesity drug Mounjaro in a KwikPen presentation, the ...

Houston’s Axiom Space launched its fourth human spaceflight mission on Wednesday. One of the mission’s experiments hopes to ...

Medtronic, Beta Bionics and Tandem Diabetes Care showcased planned patch pumps at the conference, while Senseonics shared ...

While many systems already pair continuous glucose monitors (CGMs) and insulin pumps, PharmaSens and SiBionics may have ...

CHICAGO -- A once-weekly basal insulin had similar safety and efficacy to a daily insulin option, a series of trials from the ...